A return to the peak of the 2017 bull market could signal “major macro highs” for Bitcoin, but this time, institutions are here, says analyst Philip Swift.
Bitcoin, mining, BTCRead More
You might also be interested in reading Castle Biosciences raises 2025 revenue guidance to $310M–$320M following strong Q2 execution and test volume growth.